From what I understand, BOS suspension is purely related to the...

  1. 1,419 Posts.
    lightbulb Created with Sketch. 36
    From what I understand, BOS suspension is purely related to the change in activities.

    However, the valuation of BOS of about 5 million dollars in the RGM transaction would probably be based upon BOS sale of it's intellectual property to CBI. CBI in turn, probably can't pay for BOS technology without GL Biochem taking them over.

    That's my take anyway. So if you read an announcement in the near future that says CBI (CBTE) and GL Biochem have completed their merger, then all is good.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.